The Threshold of Pain and Neurotransmitter's Change on Pain in Parkinson's Disease
- 1 September 1990
- journal article
- research article
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 44 (3) , 589-593
- https://doi.org/10.1111/j.1440-1819.1990.tb01634.x
Abstract
Among Parkinson's disease (PD) patients complaining of pain, 10 with pain not associated with a motor fluctuation or L-dopa therapy were evaluated. The controls were 14 PD without pain and eight with thalamic pain syndrome. The threshold of pain and neurotransmitters in CSF were measured in the three groups. In PD with pain, the maximum tolerance level and tourniquet pain ratio decreased significantly. In PD with pain, the score on the self-depression scale increased significantly and 5-hydroxy-indole acetic acid (5-HIAA) among the neurotransmitters decreased significantly. These results suggest that decreases in the threshold of pain and changes of serotonin in CSF are involved in the development of specific pain in PD who do not respond to L-dopa.Keywords
This publication has 17 references indexed in Scilit:
- Amitriptyline in the treatment of headache in patients with Parkinson's diseaseNeurology, 1988
- Doctors, drugs, and the DHSSBMJ, 1984
- Sensory symptoms in Parkinson's diseaseNeurology, 1984
- Administration of levodopa for relief of herpes zoster painPublished by American Medical Association (AMA) ,1981
- “Mini-mental state”Journal of Psychiatric Research, 1975
- Levodopa and induced-pain response. A study of patients with Parkinsonian and pain syndromesArchives of internal medicine (1960), 1973
- Autonomic Deficits in Parkinson's SyndromeArchives of Neurology, 1971
- ParkinsonismNeurology, 1967
- “Psychogenic” pain and the pain-prone patientThe American Journal of Medicine, 1959
- "Psychogenic" PainMedical Clinics of North America, 1958